The Royal Children’s Hospital Melbourne has devised an effective nursing guideline for management of intravenous access devices in outpatient and homecare settings. Aseptic techniques should be employed when placing the intravenous access devices in the blood veins with precise positioning to prevent complications such as phlebitis, extravasation, infiltration and hematoma. The intravenous cannula should be protected by dressing the site of insertion, place a cotton ball underneath the hub of the cannula to reduce the pressure and cover the cannula site with sterile occlusive dressings to prevent infection.

Intravenous access devices market comprises of products such as peripheral vascular access system and central vascular access system. Medication administration, administration of fluid and nutrition, transfusion of blood products and diagnostic testing are included in the applications segment. Market estimation and data forecast for duration 2015-2025 is given for the product and application segment respectively.

For the geographic segmentation the data forecast and market estimation is included in the scope of the report.

Competitive landscape elucidates the competition in the intravenous access devices market, the different strategies employed by cardinal players to capitalize the market. Attractive investment proposition gives clear idea while considering the regional market as an investment destination the Porter’s five forces model. The business milieu in the intravenous access market is understood by the cardinal players in the intravenous access devices market are GE Healthcare, Inc., Baxter International, Inc., B. Braun Medical, Inc., Becton Dickinson and Company, Edward Life Sciences Corporation, Medtronic Plc, Nipro Medical Corporation, Terumo Corporation, Teleflex Medical and Siemens Medical Solutions, Inc.

Intravenous cannulation is a procedure in which the cannula is placed inside the veins which provides intravenous access for administration of parenteral nutrition, blood sampling, administration of IV fluids and chemotherapy medicines. The veins has three layered wall composed of internal endothelium surrounded by thin layers of muscle fibers and connective tissues; understanding of veins morphology is important in the manufacturing of catheters or it might lead to major complications such as thrombophlebitis, air embolism, extravasation and hematoma. The peripheral vascular access system has huge demand for short term therapies like administration of antipyretics, analgesics, antibiotics and collecting blood samples for diagnostics purposes. Central vascular access system is finding huge demand for long term therapies such as chemotherapy, cardiovascular disease treatment and parenteral nutrition. Major players in intravenous access devices market are Baxter International, Inc., B. Braun Medical, Inc., Becton Dickinson and Company, Edward Life Sciences Corporation, GE Healthcare, Inc., Medtronic Plc, Nipro Medical Corporation, Siemens Medical Solutions, Inc., Teleflex Medical and Terumo Corporation.

According to a report published by World Health Organization, globally cancer is the second leading causes of death. In 2015, around 8.8 million died due to cancer as the patients did not gain access to effective chemotherapy. Chronic diseases such as cardiac complications, lung disorders, and diabetes are responsible for 60 % of the deaths globally. Medication administration and diagnostic testing together dominate the application segment as it is driven by rising prevalence of chronic diseases requiring immediate intravenous drug delivery, and withdrawing of blood sample for diagnosis of contagious diseases such as malaria, dengue and water borne diseases. Administration of fluids and nutrition and transfusion of blood products is set to grow rapidly due to increasing cases of traumatic accidents resulting in heavy blood loss. Fluids and nutrition administration will accelerate the market growth because its intravenous administration is necessary to treat disorders such as typhoid, cholera, malnutrition, etc., which if unchecked can result into death of ailing patient.

Advanced diagnostic screening and domicile of prominent manufacturers are responsible for superiority of North America in the intravenous access devices market. Intravenous access devices market seeks a lucrative market growth in Europe due to presence of rare blood disorder diseases requiring frequent blood transfusion, and high risk incidence for communicable diseases due to recent immigration influx. The hot and humid weather conditions in Asia Pacific are responsible for the rise in tropical disease which requires immediate intravenous medication administration. The presence of existing and budding companies manufacturing intravenous access devices is expected to contribute impressive growth of Asia Pacific region in the near future. World Health Organization and Red Cross are actively involved in the provision of intravenous access devices to the Middle East and Africa region to fight life threatening diseases. Proactive role of government health agencies in setting primary healthcare centers in Latin America causes huge demand for intravenous access devices in the region.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Intravenous Access Devices market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Intravenous Access Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Intravenous Access Devices market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Intravenous Access Devices market?
• Which is the largest regional market for Intravenous Access Devices market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Intravenous Access Devices market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Intravenous Access Devices market worldwide?